Annual Report 2025

Change report

Consolidated statement of financial position

Consolidated statement of financial position

as of December 31, € in millions

 

Note

 

2025

 

2024

Assets

 

 

 

 

 

 

Cash and cash equivalents

 

15

 

1,585

 

2,282

Trade accounts and other receivables,
less allowances for expected credit losses

 

16

 

3,558

 

3,500

Inventories

 

17

 

2,611

 

2,573

Other financial assets

 

18

 

1,915

 

1,422

Other assets

 

19

 

1,127

 

1,145

Income tax receivables

 

 

 

220

 

214

Assets held for sale

 

2

 

11

 

310

I. Total current assets

 

 

 

11,027

 

11,446

Property, plant and equipment

 

20

 

8,488

 

8,569

Right-of-use assets

 

34

 

1,231

 

1,321

Goodwill

 

21

 

14,527

 

15,085

Other intangible assets

 

21

 

2,189

 

2,422

Fresenius Medical Care investment
accounted for using the equity method

 

22

 

2,813

 

3,639

Other financial assets

 

18

 

465

 

426

Other assets

 

19, 22

 

269

 

231

Deferred taxes

 

11

 

386

 

411

II. Total non-current assets

 

 

 

30,368

 

32,104

Total assets

 

 

 

41,395

 

43,550

 

 

 

 

 

 

 

Liabilities and shareholders’ equity

 

 

 

 

 

 

Trade accounts payable

 

 

 

1,309

 

1,359

Debt

 

26

 

718

 

746

Lease liabilities

 

34

 

169

 

172

Bonds

 

27

 

584

 

1,854

Other financial liabilities

 

24

 

2,599

 

1,549

Other liabilities

 

25

 

2,142

 

2,094

Provisions

 

23

 

736

 

663

Income tax liabilities

 

 

 

115

 

148

Liabilities directly associated with
the assets held for sale

 

2

 

11

 

424

A. Total short-term liabilities

 

 

 

8,383

 

9,009

Debt

 

26

 

883

 

1,740

Lease liabilities

 

34

 

1,242

 

1,328

Bonds

 

27, 28

 

8,337

 

7,737

Other financial liabilities

 

24

 

281

 

965

Other liabilities

 

25

 

260

 

252

Pension liabilities

 

29

 

529

 

605

Provisions

 

23

 

712

 

717

Income tax liabilities

 

 

 

404

 

280

Deferred taxes

 

11

 

597

 

627

B. Total long-term liabilities

 

 

 

13,245

 

14,251

I. Total liabilities

 

 

 

21,628

 

23,260

A. Noncontrolling interests

 

30

 

663

 

748

Subscribed capital

 

31

 

563

 

563

Capital reserve

 

31

 

4,315

 

4,315

Other reserves

 

31

 

14,751

 

14,038

Accumulated other comprehensive income (loss)

 

32

 

-525

 

626

B. Total Fresenius SE & Co. KGaA shareholders’ equity

 

 

 

19,104

 

19,542

II. Total shareholders’ equity

 

 

 

19,767

 

20,290

Total liabilities and shareholders’ equity

 

 

 

41,395

 

43,550

The following notes are an integral part of the consolidated financial statements.